narciclasine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evidente, A; Kiss, R; Kornienko, A; Lefranc, F; Mathieu, V; Van Goietsenoven, G | 1 |
| Ariki, Y; Kitahara, M; Kitano, M; Mikami, M; Mimaki, Y; Sashida, Y; Yamazaki, M; Yui, S | 1 |
1 review(s) available for narciclasine and Disease Models, Animal
| Article | Year |
|---|---|
Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Brain Neoplasms; Cohort Studies; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Glioblastoma; GTP Phosphohydrolases; Humans; In Vitro Techniques; Melanoma; Mice; Molecular Targeted Therapy; Neoplasms; Phenanthridines; Structure-Activity Relationship; Transplantation, Heterologous; Treatment Outcome | 2013 |
1 other study(ies) available for narciclasine and Disease Models, Animal
| Article | Year |
|---|---|
Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Arthritis, Experimental; Cell Division; Disease Models, Animal; Drug Interactions; Leukocyte L1 Antigen Complex; Magnoliopsida; Male; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Neural Cell Adhesion Molecules; Neutrophils; Phenanthridines; Phytotherapy; Protein Synthesis Inhibitors; Rats; Rats, Wistar | 1999 |